C
Carole Soussain
Researcher at Curie Institute
Publications - 148
Citations - 5931
Carole Soussain is an academic researcher from Curie Institute. The author has contributed to research in topics: Primary central nervous system lymphoma & Medicine. The author has an hindex of 32, co-authored 118 publications receiving 4617 citations. Previous affiliations of Carole Soussain include Institut Gustave Roussy & French Institute of Health and Medical Research.
Papers
More filters
Journal ArticleDOI
Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma
Lauren E. Abrey,Tracy T. Batchelor,A. J. M. Ferreri,Mary Gospodarowicz,Elisa Jacobsen Pulczynski,Emanuele Zucca,Justine R. Smith,Agnieszka Korfel,Carole Soussain,Lisa M. DeAngelis,Edward A. Neuwelt,Brian P. O'Neill,Eckhard Thiel,Tamara Shenkier,Fransesc Graus,Martin J. van den Bent,John F. Seymour,Philip Poortmans,James O. Armitage,Franco Cavalli +19 more
TL;DR: An international group of experts meeting to review current standards of reporting and to formulate a consensus opinion regarding minimum baseline evaluation and common standards for assessing response to therapy hope that these guidelines will improve communication among investigators and comparability among clinical trials in a way that will allow to develop better therapies for patients.
Journal ArticleDOI
Chemotherapy delivery issues in central nervous system malignancy: a reality check.
Leslie L. Muldoon,Carole Soussain,Kristoph Jahnke,Conrad E. Johanson,Tali Siegal,Quentin R. Smith,Walter A. Hall,Kullervo Hynynen,Peter D. Senter,David M. Peereboom,Edward A. Neuwelt +10 more
TL;DR: Because of the difficulty in treating CNS tumors, innovative treatments and alternative delivery techniques involving brain/cord capillaries, choroid plexus, and CSF are needed.
Journal ArticleDOI
CNS complications of radiotherapy and chemotherapy
Carole Soussain,Carole Soussain,Damien Ricard,Damien Ricard,John R. Fike,Jean Jacques Mazeron,Dimitri Psimaras,Jean-Yves Delattre,Jean-Yves Delattre +8 more
TL;DR: The most important and controversial complications of radiotherapy, chemotherapy, and combined treatments in the CNS are reviewed, and new diagnostic tools, practical management, prevention, and pathophysiological data that will affect future management of patients with cancer are discussed.
Journal ArticleDOI
Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology
Khê Hoang-Xuan,E M Bessell,Jacoline E C Bromberg,Andreas F. Hottinger,Matthias Preusser,Roberta Rudà,Uwe Schlegel,Tali Siegal,Carole Soussain,Carole Soussain,Ufuk Abacioglu,Nathalie Cassoux,Martina Deckert,Clemens M F Dirven,Andrés J.M. Ferreri,Francesc Graus,Roger Henriksson,Ulrich Herrlinger,Martin J.B. Taphoorn,Riccardo Soffietti,Michael Weller +20 more
TL;DR: These guidelines provide consensus considerations and recommendations for diagnosis, assessment, staging, and treatment of primary CNS lymphoma and should aid clinicians in their daily practice and decision making, and serve as a basis for future investigations in neuro-oncology.
Journal ArticleDOI
Results of Intensive Chemotherapy Followed by Hematopoietic Stem-Cell Rescue in 22 Patients With Refractory or Recurrent Primary CNS Lymphoma or Intraocular Lymphoma
Carole Soussain,Florence Suzan,Khê Hoang-Xuan,Nathalie Cassoux,Vincent Levy,Nabih Azar,Coralie Belanger,Eddine Achour,Vincent Ribrag,Sophie Gerber,Jean-Yves Delattre,Véronique Leblond +11 more
TL;DR: IC + HCR proved feasible and effective in patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma and the entire procedure seemed to be most toxic in patients > or = 60 years.